Narrow search
Showing 1 - 10 of 657
Cover Image
Does pharmaceutical price regulation affect the adoption of generic competition? Evidence from the OECD, 1999-2008
Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - 2011
Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to...
Persistent link: https://www.econbiz.de/10010274736
Cover Image
Explaining early adoption on new medicines: Regulation, innovation and scale
Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - 2011
Understanding how price regulations affect the adoption of new patent-protected pharmaceutical technologies is a crucial question in designing health systems. This paper addresses this question by examining how price expectations shape the probability of launch, controlling for competition,...
Persistent link: https://www.econbiz.de/10010274894
Cover Image
Price regulation and relative delays in generic drug adoption
Costa-Font, Joan; McGuire, Alistair; Varol, Nebibe - In: Journal of health economics 38 (2014), pp. 1-9
Persistent link: https://www.econbiz.de/10011282079
Cover Image
Regulation effects on the adoption of new medicines
Costa-Font, Joan; McGuire, Alistair; Varol, Nebibe - In: Empirical economics : a journal of the Institute for … 49 (2015) 3, pp. 1101-1121
Persistent link: https://www.econbiz.de/10011377336
Cover Image
Does adoption of pharmaceutical innovation respond to changes in the regulatory environment?
Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - In: Applied economic perspectives and policy 34 (2012) 3, pp. 531-553
Persistent link: https://www.econbiz.de/10009721541
Cover Image
Explaining Early Adoption on New Medicines : Regulation, Innovation and Scale
Varol, Nebibe - 2014
Understanding how price regulations affect the adoption of new patent-protected pharmaceutical technologies is a crucial question in designing health systems. This paper addresses this question by examining how price expectations shape the probability of launch, controlling for competition,...
Persistent link: https://www.econbiz.de/10013067984
Cover Image
Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition? Evidence from the OECD, 1999-2008
Varol, Nebibe - 2014
Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to...
Persistent link: https://www.econbiz.de/10013068052
Cover Image
Does pharmaceutical price regulation affect the adoption of generic competition? : evidence from the OECD, 1999-2008
Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - 2011
Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to...
Persistent link: https://www.econbiz.de/10009124143
Cover Image
Explaining early adoption on new medicines : regulation, innovation and scale
Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - 2011
Understanding how price regulations affect the adoption of new patent-protected pharmaceutical technologies is a crucial question in designing health systems. This paper addresses this question by examining how price expectations shape the probability of launch, controlling for competition,...
Persistent link: https://www.econbiz.de/10009127576
Cover Image
Do International Launch Strategies of Pharmaceutical Corporations Respond to Changes in the Regulatory Environment?
Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - In: The LSE Companion to Health Policy
The LSE Companion to Health Policy covers a wide range of conceptual and practical issues from a number of different perspectives introducing the reader to, and summarising, the vast literature that analyses the complexities of health policy. The Companion also assesses the current state of the art.
Persistent link: https://www.econbiz.de/10011177551